After weathering a historically volatile month in March, trading activity on OTC Markets abated somewhat in April, reflecting a relative calmness in market conditions compared to the previous month.
Trading volume on OTC Markets decreased in April, and nearly all of the market’s most actively traded securities experienced month-over-month volume declines as market volatility normalized a bit during the month. Volume on the OTCQX Market—the top tier of OTC Markets— fell 37% in April, while volume on the OTCQB Venture Market decreased 24%.
On an individual company level, nearly all of the most actively traded securities on OTC Markets experienced lighter dollar volume in April than in March, a likely result of lower share prices combined with lower volatility. This includes names like Roche Holding Ltd (OTCQX: RHHBY) (down 39%), the Grayscale Bitcoin Trust (OTCQX: GBTC) (down 21%), and Adidas AG (OTCQX: ADDYY) (down 70%).
Of the 30 most-traded securities on the OTCQX Market, only Air Canada (OTCQX: ACDVF) (up 38%) and New Pacific Metals Corp. (OTCQX: NUMF) (up 27%) saw a dollar volume increase in April, while Cresco Labs Inc. (OTCQX: CRLBF) was flat month-over-month.
On the OTCQB Venture Market, CytoDyn Inc. (OTCQB: CYDY) was the most actively traded security on the market for the first time on record, as dollar volume in the issuer increased 191%. This massive increase is most likely related to the company’s Leronlimab, which is currently in the Phase 2 testing period to potentially treat severely-ill COVID-19 patients.
Shares of CytoDyn were so actively traded during April, that they accounted for nearly half of all dollar volume on the entire OTCQB Market.
Below are the top 10 most actively traded securities on the OTCQX and OTCQB Markets in April.
Roche Holding Ltd
Grayscale Bitcoin Trust
Infineon Technologies AG
Anglo American plc
Semler Scientific, Inc.
Kraig Biocraft Laboratories, Inc.
Innovation Pharmaceuticals Inc.
CV Sciences, Inc.
Algernon Pharmaceuticals Inc.
Northwest Biotherapeutics, Inc.
Nextech AR Solutions Corp.
See more from Benzinga
© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.